Chemokine Compartmentalization and Neutrophil Accumulation in the Lung

肺部趋化因子区室化和中性粒细胞积聚

基本信息

  • 批准号:
    8187532
  • 负责人:
  • 金额:
    $ 41.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-15 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cells react to microorganisms by activating inflammatory mechanisms that attract neutrophils, dependent in part on ELR+ CXC chemokines, whose localization within specific compartments (plasma, erythrocyte, airspace, endothelium among others) influences their activity. We hypothesize that the availability of chemokine binding sites on the non-receptor molecules Duffy antigen receptor for chemokines (DARC) and heparan sulfate proteoglycans (HSPG) for CXCL1 is determined, in part, by specific molecular forms of the chemokines CXCL5 and 7. We further propose that binding site availability regulates neutrophil accumulation in the lung. Preliminary findings indicate that targeted deletion of CXCL5 in mouse exerts dichotomous effects on inflammation. CXCL5-/- mice respond to inhaled LPS with decreased neutrophil accumulation, but respond to E coli with increased neutrophil accumulation and improved bacterial clearance. Using both human (primary alveolar type II cells in culture) and murine systems (newly- generated targeted deletions of CXCL5 and CXCL7), we pursue 3 specific aims focused on the potential role of CXCL5 in modulating neutrophil accumulation and host defense. In Aim 1, We define the effect of CXCL5 and CXCL7 on chemokine scavenging and lung inflammation. In Aim 2, we propose to determine the extent to which CXCL5 and CXCL7 binding to DARC and HSPG modifies transalveolar movement of chemokines and hence, inflammatory responses. In Aim 3 we will determine the sites and molecular forms of chemokines bound in the lung endovascular compartment. Understanding the disposition of chemokines, and how they interact will define fundamental mechanisms of kinetics and localization of chemokines, offer promise in diagnostic and predictive algorithms, and permit therapeutic alteration of disease due to sepsis and pneumonia. PUBLIC HEALTH RELEVANCE: Targeted deletion of CXCL5 in mouse increases the neutrophil response to E coli pneumonia and improves bacterial clearance CXCL5, and the closely related chemokine CXCL7 are uniquely suited to influence the binding of many other chemokines to their non-receptor binding molecules DARC and HSPG. By highlighting mechanisms by which chemokines are sequestered and presented by binding molecules these studies present a novel model of the inflammatory response in the lung.
描述(由申请方提供):细胞通过激活炎症机制对微生物进行反应,炎症机制吸引中性粒细胞,部分依赖于ELR+ CXC趋化因子,其在特定隔室(血浆、红细胞、气腔、内皮等)中的定位影响其活性。我们假设,趋化因子结合位点的非受体分子达菲抗原受体趋化因子(DARC)和硫酸乙酰肝素蛋白聚糖(HSPG)的CXCL 1的可用性,部分是由特定的分子形式的趋化因子CXCL 5和7。我们进一步提出,结合位点的可用性调节中性粒细胞在肺中的积累。初步研究结果表明,CXCL 5在小鼠中的靶向缺失对炎症产生二分作用。CXCL 5-/-小鼠对吸入LPS的反应是中性粒细胞积聚减少,但对大肠杆菌的反应是中性粒细胞积聚增加和细菌清除改善。使用人(培养的原代肺泡II型细胞)和鼠系统(新产生的CXCL 5和CXCL 7的靶向缺失),我们追求3个特定目标,集中于CXCL 5在调节中性粒细胞积累和宿主防御中的潜在作用。目的1:明确CXCL 5和CXCL 7对趋化因子清除和肺部炎症的作用。在目的2中,我们提出确定CXCL 5和CXCL 7与DARC和HSPG结合在多大程度上改变趋化因子的跨肺泡运动,从而改变炎症反应。在目标3中,我们将确定在肺血管腔内室结合的趋化因子的位点和分子形式。了解趋化因子的处置,以及它们如何相互作用将定义趋化因子的动力学和定位的基本机制,提供诊断和预测算法的希望,并允许由于败血症和肺炎引起的疾病的治疗改变。 公共卫生相关性:小鼠中CXCL 5的靶向缺失增加了嗜中性粒细胞对大肠杆菌肺炎的反应并改善了细菌清除CXCL 5,并且密切相关的趋化因子CXCL 7独特地适合于影响许多其他趋化因子与其非受体结合分子DARC和HSPG的结合。通过强调趋化因子被结合分子隔离和呈递的机制,这些研究提出了一种新的肺部炎症反应模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George SCOTT WORTHEN其他文献

George SCOTT WORTHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George SCOTT WORTHEN', 18)}}的其他基金

CXC Chemokines and Regulation of Granulopoiesis
CXC趋化因子和粒细胞生成的调节
  • 批准号:
    8439395
  • 财政年份:
    2013
  • 资助金额:
    $ 41.88万
  • 项目类别:
CXC Chemokines and Regulation of Granulopoiesis
CXC 趋化因子和粒细胞生成的调节
  • 批准号:
    8800537
  • 财政年份:
    2013
  • 资助金额:
    $ 41.88万
  • 项目类别:
CXC Chemokines and Regulation of Granulopoiesis
CXC趋化因子和粒细胞生成的调节
  • 批准号:
    8636398
  • 财政年份:
    2013
  • 资助金额:
    $ 41.88万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8302274
  • 财政年份:
    2011
  • 资助金额:
    $ 41.88万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8682900
  • 财政年份:
    2011
  • 资助金额:
    $ 41.88万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8499406
  • 财政年份:
    2011
  • 资助金额:
    $ 41.88万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8477060
  • 财政年份:
    2010
  • 资助金额:
    $ 41.88万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8310970
  • 财政年份:
    2010
  • 资助金额:
    $ 41.88万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    7869879
  • 财政年份:
    2010
  • 资助金额:
    $ 41.88万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8109409
  • 财政年份:
    2010
  • 资助金额:
    $ 41.88万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了